|
HS Code |
767109 |
| Chemical Name | N-Glycyl-L-Tyrosine |
| Cas Number | 658-79-7 |
| Molecular Formula | C11H14N2O4 |
| Molecular Weight | 238.24 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Melting Point | 220-225°C (decomposition) |
| Ph 1 Solution | 5.0-7.0 |
| Purity | Typically ≥98% |
| Iupac Name | 2-[[(2S)-2-amino-2-oxoethyl]amino]-3-(4-hydroxyphenyl)propanoic acid |
As an accredited N-Glycyl-L-Tyrosine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | N-Glycyl-L-Tyrosine is supplied in a 1g amber glass vial with a secure screw cap, labeled with product details. |
| Shipping | N-Glycyl-L-Tyrosine is shipped in tightly sealed containers to protect it from moisture and contamination. It is typically dispatched at ambient temperature but may require cold pack shipping for long-duration transport. The package is clearly labeled as a chemical, and all relevant safety and handling documentation is included. |
| Storage | N-Glycyl-L-Tyrosine should be stored in a cool, dry, and well-ventilated location. Keep the container tightly sealed, away from moisture, heat, and direct sunlight. Store at room temperature or as specified by the manufacturer. Avoid exposure to strong oxidizing agents. Proper storage ensures product stability and minimizes the risk of decomposition or contamination. |
Applications of N-Glycyl-L-Tyrosine in Industrial ManufacturingN-Glycyl-L-Tyrosine finds established use in a select group of downstream manufacturing sectors that require peptide building blocks for precision synthesis and quality assurance. Here we detail its applications in relevant fields, including compliance frameworks, formulation ranges, integration points within downstream processes, and resulting finished product types. 1. Peptide Therapeutic ManufacturingPeptide drug producers incorporate N-Glycyl-L-Tyrosine as an essential dipeptide during the solid-phase peptide synthesis (SPPS) of pharmacological agents, especially where this building block supports increased purity and sequence accuracy for target molecules. Adherence to current Good Manufacturing Practice (cGMP) requirements and global pharmacopoeial monographs forms part of standard operating procedures at peptide facilities. Typically, manufacturers adjust the proportion of dipeptide within the active peptide chain based on target sequence ratio and requirement for reduced racemization during chain elongation. Integration into production occurs during automated stepwise assembly, after resin coupling and deprotection cycles, and before cleavage and purification. Finished drugs include injectable therapeutic peptides and peptide-based APIs for oncology, metabolic disorders, and infectious disease treatment. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Cell Culture Media SupplementsProducers of cell culture media use N-Glycyl-L-Tyrosine to overcome the limited solubility and low stability of L-tyrosine in aqueous formulations. By providing a dipeptide form, manufacturers enable improved tyrosine delivery in high-density animal and mammalian cell culture processes. The raw material must meet strict ISO and USP standards for excipients and display consistently low bioburden to prevent contamination. Usage ratios depend on species and medium type but generally replace free tyrosine to stabilize feed. Downstream processing involves blending with basal powder or liquid feeds, followed by sterile filtration and packaging as pre-mixed culture media. Finished products include ready-to-use and concentrated cell culture media for CHO and hybridoma cell growth in bioreactor systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Parenteral Nutrition FormulationsManufacturers of clinical nutrition blends use N-Glycyl-L-Tyrosine to provide a stable, water-soluble source of tyrosine for intravenous administration, particularly in total parenteral nutrition (TPN). Its improved solubility over free tyrosine ensures adequate delivery of this essential amino acid in premixed nutrition bags, addressing both pediatric and adult clinical needs. Product quality must align with major pharmacopeial and food additive guidelines, and assure pharmacological purity. The dipeptide is blended at levels matched to individual patient amino acid requirements, adjusted by medical teams based on age, weight, and condition. Facilities add it into sterile solution tanks prior to final filtration, filling, and terminal sterilization. Final outputs consist of single- and multi-chamber TPN bags distributed to hospitals and home-care providers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Nutritional Supplement Premix ProductionDietary supplement manufacturers employ N-Glycyl-L-Tyrosine as a specialty ingredient in formulation of performance, sports, and medical nutrition premixes. This form offers higher solubility, more predictable release, and improved shelf-stability compared to single amino acid sources, meeting consumer expectations for advanced supplementation. Facilities must comply with regional food additive and supplement ingredient regulations, as well as relevant ISO and HACCP quality systems. Dosing ratios reflect permitted claims for dipeptide supplementation and intended serving size, and vary according to application such as powdered formulas versus ready-to-drink beverages. Production lines blend the dipeptide with other amino acids, vitamins, and minerals, directly before granulation, tableting, or liquid bottling. Marketed products include energy drink powders, sports tablets, fortified dietary bars, and clinical-grade medical nutrition sachets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-Glycyl-L-Tyrosine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of hands-on work with peptide synthesis have shown us the difference a single molecule can make in research and production. N-Glycyl-L-Tyrosine has become an essential part of our catalog, not just because of its chemical properties, but because it works reliably for chemists, pharmacists, formulators, and nutrition scientists alike. We develop our N-Glycyl-L-Tyrosine with tight control over purity, particle size, and moisture—our everyday effort ensures users encounter reliable material batch after batch.
Our process relies on peptide bond formation, giving us flexibility to meet industry demand for high-purity dipeptides. Each batch of N-Glycyl-L-Tyrosine follows exacting standards for appearance, solubility, and identification. We use methods such as HPLC and NMR to ensure consistency, not just on paper, but across kilograms of product. By investing in stringent quality checks and real-world feedback from formulators, we’ve reduced batch variability to an absolute minimum.
N-Glycyl-L-Tyrosine stands out because of its amino acid composition: one glycine linked to a tyrosine by an amide bond. Experience taught us to watch out for by-product formation and racemization in synthesis. Unchecked, these issues can create material unsuitable for precise work in peptide research or application in nutritional supplements. Every time we adjust temperature or solvent, our technicians measure the effects directly, keeping close records for traceability and reproducibility. Over the years, we’ve nudged our process parameters, avoiding pitfalls like peptide hydrolysis or incomplete reactions. Since we handle scale-ups ourselves, process know-how is passed directly to every batch.
The real-world value of N-Glycyl-L-Tyrosine becomes obvious in the lab. Researchers trust purity. We maintain a chemical purity above 98%—validated by chromatographic and spectroscopic analysis. Impurities can interfere with downstream applications or affect data reliability in profiling, so our long-term customers choose product lots based on consistently low levels of residual solvents, heavy metals, and other peptides.
Moisture content plays a quieter but critical role, too. A batch with excessive moisture can affect weighing, dissolution, or storage stability. Our technical team measures water content by Karl Fischer titration, not just for QC paperwork, but to ensure products behave as expected in high-accuracy synthesis or formulation. Experience taught us that skipping a single moisture check can waste whole days for a client or throw off a pilot run. By stabilizing handling, drying, and packaging, we’ve protected our customers’ timelines from surprises.
We produce N-Glycyl-L-Tyrosine as a free-flowing powder, white to off-white by visual observation, and we pack according to usage scale. Researchers request small bottles, but industrial buyers prefer larger or custom packaging. Our own facility stores and ships the compound in airtight, light-resistant containers. Over the years, we found this control minimizes clumping, color change, and contamination. Each shipment comes from our controlled warehouse zone, so whoever opens the package works with material in its original, unaltered condition.
We see two main types of user: research laboratories executing peptide synthesis or biochemical studies, and companies formulating dietary supplements or nutraceuticals. The peptide structure of N-Glycyl-L-Tyrosine allows it to function both as a building block in longer peptide chains and as a component for studies involving amino acid metabolism, transport, or absorption.
Our N-Glycyl-L-Tyrosine has passed tests in cell biology and biochemical work, holding up to repetitive freeze-thaw cycles. In nutrition science, it can serve as a highly soluble source of amino acids, valued for its rapid absorption profile. We worked directly with scientists developing novel feed formulations and functional foods, observing how solubility and stability affect experimental outcomes and shelf life. Because of its dipeptide structure, it crosses cell membranes with different kinetics than the free amino acids. Many researchers saw measurable differences using our material after trying generic or impure alternatives.
Many users ask us: why not just use free glycine or free tyrosine instead of the dipeptide? Real-world research has shown that dipeptides behave differently in both chemical synthesis and biological systems. For example, N-Glycyl-L-Tyrosine is absorbed in the intestine by peptide transporters, not just those for single amino acids. This can enhance bioavailability or support different metabolic pathways.
In chemical synthesis, using the dipeptide often simplifies coupling reactions, reduces the risk of unwanted side reactions, and can improve yields for downstream products. Over the past decade, clients have reported cleaner conversion rates during peptide elongation, cleaner analytical profiles, and less time troubleshooting impure or inconsistent starting materials. Those differences in practical outcomes pushed us to standardize specifications and document storage life data years before many others recognized the benefit.
By producing N-Glycyl-L-Tyrosine in-house, we retain flexibility our customers rarely find elsewhere. Free amino acids might be widely available, but the quality of dipeptides can vary drastically depending on the process. Feedback from formulation scientists guided our decision to filter and dry the material under vacuum. Color and solubility stay consistent, and the packaging protects against photo-degradation and hydrolysis.
Quality begins at the raw material stage. Only after auditing sources for glycine and tyrosine do we approve inbound shipments. Technicians check identity and purity before feeding batches into synthesis reactors. Problems we solved in our production line—like minimizing batch-to-batch variation—translate to fewer headaches for researchers and processors down the line.
We’ve dealt firsthand with contamination issues from open-air packing and the ingress of dust or microbes during transportation. After one experience involving water absorption leading to product clumping, our team invested in improved sealing technology and revised our humidity control for storage. This change didn’t just tick a compliance box—it kept our customers’ inventory stable for longer periods in less-than-ideal warehouse conditions.
On the safety front, many N-Glycyl-L-Tyrosine users focus on the absence of harmful residues. We routinely check for heavy metals, residual solvents, and microbial burden. Modern laboratories expect and demand this data, not just for regulatory audits but for real operational safety.
Our experience goes beyond synthesis: we support clients troubleshooting technical hurdles. Occasionally, a customer will encounter unexpected solubility limits or color change. Thanks to our record-keeping on each batch, we can compare process parameters and analytical snapshots and recommend solutions—be it slight warming during dissolution or adjusting buffer composition.
Researchers working with animal models or cell cultures discovered that low-purity dipeptide sources can introduce experimental error. Thanks to rigorous purification steps and post-synthesis analytics, our produced N-Glycyl-L-Tyrosine maintains low levels of both peptide fragments and non-peptidic organic residues. Our feedback loop with customers ensures continual improvement in raw material handling, cleaning process lines, and packaging updates.
Over the last decade, new delivery systems and synthetic methodologies have called for more robust peptides, higher purity, and advanced packaging. We built flexibility into our plant by investing in modular reactors and advanced analytical instruments. These upgrades weren’t just technical—our on-job engineers and technicians received hands-on training to transition from older solvent systems to greener, more efficient workflows.
We face constant supply chain pressures—price volatility for amino acids, regulatory shifts, and demands for traceability. Our response has been to tighten supplier relationships and document every lot from origin to shipment. This traceability protects both our product and our customers’ processes, giving visible proof of compliance and safety.
Some end-users now require N-Glycyl-L-Tyrosine at customized levels of purity or tailored to specific buffer systems for preclinical or clinical projects. We achieved this by adapting our production flow—to concentrate fractions, run further purification, and support tests for compatibility with project-specific analytical methods. Our direct work with development scientists exposed us to challenges that never show up in theory—batch-to-batch color drift or subtle shifts in solubility once product sits in real-life storage.
Our team handles the compound, batch by batch, watching for anything out of norm—from crystal size to color hue and even the way powder settles in the bottle. Operators calibrate their senses to these details, supplementing equipment readings with lived experience. We learned that even a minor mishap in drying or handling can alter downstream results, so every step in our process keeps end-use applications in mind.
Customers give feedback with real data—no theory, just project results or failed pilot runs when things go wrong. We adjust. That approach reduced product complaints and improved turnaround time for custom orders or new packaging formats. N-Glycyl-L-Tyrosine remains in demand not because it’s standard, but because each delivery matches the requirements set by real science, not just regulatory minimums.
Choosing to make our own N-Glycyl-L-Tyrosine, instead of trading or outsourcing, keeps us honest and hands-on. The daily reality of manufacturing—monitoring reactors, checking purity, retooling packaging—helps us respond to new requests from R&D teams, regulatory officers, or production managers. It’s easy to ship bottles or bags, but only hands-on production gives confidence that what leaves our facility will perform consistently in end-user settings.
Innovation in peptide chemistry evolves quickly, often driven by small technical improvements and practical responses to unexpected problems. Our commitment to local, in-house production allows us to innovate, troubleshoot, and scale new solutions quickly—without waiting for external partners.
Every batch of N-Glycyl-L-Tyrosine reflects the work of people and process. Our chemists, operators, and QC teams contribute day by day to its reproducibility and suitability for sensitive applications. We have pursued continuous improvement for over a decade, and today’s product represents that journey. Working directly with users—not just selling to them—lets us see where the product succeeds and where we need to evolve next.
We believe our production approach, customer support, and transparency set N-Glycyl-L-Tyrosine apart. Feedback from scientists, pharmacists, and engineers keeps us pressing forward, balancing scientific rigor with real-world needs. Whether working at research scale or in large production runs, we continue to bring the lessons of hands-on experience to every batch delivered.